openPR Logo
Press release

Nicotinamide Mononucleotide (NMN) Market is Estimated to Observe Significant Growth of USD 34.51 billion by Growing Rapidly with Recent Industry Share, Trends, Demand, Key Findings and Forecast to 2029

06-29-2022 11:09 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Exactitude Consultancy

Nicotinamide Mononucleotide (NMN) Market Overview:

Nicotinamide mononucleotide (NMN) is a molecule that exists naturally in all living things. It is a ribonucleotide, which is the nucleic acid RNA's basic structural unit, at the molecular level. A nicotinamide group, a ribose group, and a phosphate group make up the molecule. Because it is a direct precursor of the crucial chemical nicotinamide adenine dinucleotide (NAD+), NMN is essential for boosting NAD+ levels in cells.

 The global Nicotinamide Mononucleotide (NMN) market size was valued at USD 210.64 million in 2020, and is projected to reach USD 428.14 million by 2029, growing at a CAGR 8.2% during the forecast period 2022-2029.

Get Sample Report Link:

https://exactitudeconsultancy.com/reports/3368/nicotinamide-mononucleotide-nmn-market/#request-a-sample?mode=P166

Nicotinamide Mononucleotide (NMN) Market Key Players

The study of the growth of the top market player for in the target sector includes new projects with speculative returns, innovations and study of the accessibility of companies. some of the profiled players are GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, Bontac, Shandong Sihuan Pharmaceutical, EffePharm, Zhejiang Jiahua Pharmchemicals and Others

Recent Development

NAD+ Precursors NMN and NR Prevent Nerve Fiber Degradation in Diabetes
Jun 7, 2022- Diminished NAD+ levels are restored by nicotinamide riboside (NR) treatment in nerve fibers damaged by diabetes.
Herbalmax® Announces Reinvigorator, The First NMN-Based Enhanced with Herbal Compounds for Metabolic Repair and Healthy Aging
May 18, 2018- Herbalmax®, a pioneer in natural, is excited to introduce its Reinvigorator formula, the first Nicotinamide Mononucleotide (NMN)-based supplement enhanced with synergistic herbal compounds. The Herbalmax® Reinvigorator is an advanced daily supplement designed to enhance cellular repair, metabolic optimization and energy production.

Browse Complete Premium Research Details with 120 Pages, Tables on content, List of Tables and List of Figures:

https://exactitudeconsultancy.com/reports/3368/nicotinamide-mononucleotide-nmn-market/

Nicotinamide Mononucleotide (NMN) Market Segmentation:

NMN Market By Type, 2020-2029, ( USD Million) (Kilotons)

Content Below 98%
Content Above 98%

NMN Market By Application, 2020-2029, (USD Million) (Kilotons)

Health Care Products
Cosmetics

Growth Factors:

Increasing demand from the Nicotinamide Mononucleotide (NMN) industries
The growing use of Nicotinamide Mononucleotide (NMN) in Chemical and Material Sectors.
Rising demand for products
Technological advancements in production processes
Growing applications in Nicotinamide Mononucleotide (NMN) Market

Nicotinamide Mononucleotide (NMN) Market Regional Analysis

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Fiberglass Storage Tank (Fiberglass Tank) Professional in these regions, from 2022-2029, covering

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Get Sample PR Link @

https://exactitudeconsultancy.com/post/nicotinamide-mononucleotide-nmn-market-growth/

Key Nicotinamide Mononucleotide (NMN) Market Trends

- The report identifies, determines, and forecasts the Global Nicotinamide Mononucleotide (NMN) Market segments based on their type, sub-type, technology used, applications, end-users, and regions.

- Industry to Industry Holds Largest Share in the Nicotinamide Mononucleotide (NMN) Market

- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.

- Demand from Regional / geographical is expected to drive the Growth

- Rising Adoption of Market Segments in the Nicotinamide Mononucleotide (NMN) Growth

- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Nicotinamide Mononucleotide (NMN) Market.

Frequently Asked Questions

What are the challenges for the Nicotinamide mononucleotide (NMN) market created by the outbreak of the global pandemic?
What are the drivers that are shaping the Nicotinamide mononucleotide (NMN) market?
What are the top opportunities that are currently ruling the market?
What are the segments of the Nicotinamide mononucleotide (NMN) market that are given in the report?

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

Connect us on:
Youtube Channel@ - https://www.youtube.com/watch?v=O_O7ntuM8nY&list=PLqhG4LHMp-Ocv-5aAsyiSlfdwDXu3FKxI
Linkedin - https://www.linkedin.com/company/exactitudeconsultancy/
Twitter- https://twitter.com/ExactitudeCons
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nicotinamide Mononucleotide (NMN) Market is Estimated to Observe Significant Growth of USD 34.51 billion by Growing Rapidly with Recent Industry Share, Trends, Demand, Key Findings and Forecast to 2029 here

News-ID: 2665988 • Views:

More Releases from Exactitude Consultancy

Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 billion by 2034
Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 b …
Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and blood. Despite advances in frontline therapies, relapse is common, and many patients develop refractory disease, leaving limited treatment options and poor survival outcomes. Relapsed/refractory AML (R/R AML) remains a major unmet clinical need. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71571 In recent years, however, the
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around 3% of all childhood cancers but is the most common intraocular malignancy in children. With improved awareness, early screening, and advances in treatment, survival rates in developed nations exceed 90%. However, challenges remain in low- and middle-income countries where delayed diagnosis and limited access to
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Lymphoma, a group of blood cancers affecting the lymphatic system, is broadly classified into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). While survival outcomes have improved significantly with chemotherapy, radiotherapy, targeted agents, and immunotherapies, many patients experience severe toxicities as side effects of treatment. These toxicities - ranging from cytokine release syndrome (CRS) and neurotoxicity in CAR-T therapy to myelosuppression, infections, and organ toxicities from chemotherapy and immunomodulators - can
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft tissue neoplasms are abnormal growths arising from connective tissues, including muscles, fat, nerves, tendons, and blood vessels. While some are benign, malignant forms such as soft tissue sarcomas (STS) pose serious clinical challenges due to their aggressive nature, rarity, and diverse histological subtypes. Representing about 1% of all adult cancers, these neoplasms require a wide spectrum of treatments ranging from surgery and radiotherapy to chemotherapy and novel targeted therapies. Download

All 5 Releases


More Releases for NMN

Liposomal NMN vs. Standard NMN: What One Needs to Know
Introduction: Why Your NMN Needs Protection Still taking "naked" NMN? Without protection, much of it is lost in digestion before it can make a difference. Liposomal NMN uses cutting-edge encapsulation to bypass the digestive system, protect the active ingredient, and deliver it straight to target cells - for stability, efficiency, and results. Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-08/640.png Why Regular NMN Falls Short NMN is absorbed through a special intestinal transporter (SLC12A8) to raise NAD levels in the
NMN Powder Market Research Report 2025
Global Info Research announces the release of the report "Global NMN Powder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides a detailed overview of the NMN Powder market scenario, including a thorough analysis of the NMN Powder market size, sales quantity, average price, revenue, gross margin and market share.The NMN Powder report provides an in-depth analysis of the competitive landscape, manufacturer's profiles, regional and
Nicotinamide Mononucleotide (NMN) Market Growth, Trends, and Opportunities From …
A newly published report by Exactitude Consultancy on the "Nicotinamide Mononucleotide (NMN) Market 2025" offers a detailed overview of the industry, featuring insights into competitive landscapes and market segments. The report incorporates graphs, tables, and charts to present data in a user-friendly format, making it easy to analyze and compare figures. Serving as a central source of market information, the research highlights key challenges and future growth opportunities. Additionally, the
NAD-based Anti-Aging Market Top Players - GenF20 Liposomal NMN, Wonderfeel, part …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Type (Supplements (Oral NAD Dietary Supplements, Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), Distribution Channel (Supermarkets & Hypermarkets, Specialty Stores, Convenience Stores, Pharmacies/Clinics, Online Stores)
Liposomal NMN: The Ultimate Solution for Anti-Aging
Liposomal NMN by Genuine Purity stands out in the crowded field of anti-aging product with its advanced formulation designed to boost NAD+ levels effectively. NMN, or Nicotinamide Mononucleotide, is a precursor to NAD+ (Nicotinamide Adenine Dinucleotide), a critical coenzyme involved in numerous cellular processes, including energy metabolism and DNA repair. Genuine Purity's liposomal delivery system ensures that NMN is absorbed efficiently, maximizing its benefits. [https://bit.ly/3VvcRMx] The liposomal encapsulation technology used in
llabs. Now Offers Revolutionary Healthy Aging Product: NMN
llabs., a leader in health supplements focused on promoting healthy aging, proudly announces the launch of its flagship product, NMN, alongside its complementary products, TMG Betaine and Fisetin. These innovative products are set to provide valuable support for those looking to maintain their vitality and well-being as they age. llabs., known for its commitment to quality and global reach, introduces NMN as the hero product, designed to support healthy aging and